Genedrive plc (AIM: GDR) has highlighted a new case study published by the National Institute for Health and Care Research examining the development, clinical validation and adoption of its Genedrive
RNS Hotlist with Zak Mir: HSBA, MPAL, VUL, SYNT, GEX, KEFI, GDR, GWMO & GMET
The Telegraph: Burnham allows Pc Harper’s killers to walk free early. Criminals guilty of manslaughter eligible for release halfway through sentence following PM’s review of scheme.
Genedrive Expands European Adoption with Erasmus MC Implementation
Genedrive PLC (AIM: GDR) has announced that its Genedrive® MT-RNR1 ID Kit has been implemented at Erasmus MC University Medical Center in Rotterdam, expanding the international adoption of its rapid
Share Talk Weekly Stock Market News Review, Sunday 19th July 2026
London’s FTSE 100 outperformed global peers on Friday as defensive utilities and energy stocks helped offset wider market weakness driven by a sell-off in technology and semiconductor shares. The blue-chip
Genedrive Expects FY26 Income to Rise 40% as NHS Adoption Expands
genedrive plc (AIM: GDR) expects to report total income of £1.4 million for the year ended 30 June 2026, up from around £1.0 million in FY25 and in line with
RNS Hotlist with Zak Mir: HALO, DGQ, APTA, OBI, GDR, EGT, PYC & 80M
Share Talk Weekly Stock Market News Review, Sunday 12th July 2026
FTSE 100 Closes Higher as Vodafone Surges 13% and easyJet Jumps on Apollo Bid 📈 The FTSE 100 ended higher on Friday in calmer trading, helped by a double-digit rise
Genedrive technology showcased in Parliament
Genedrive plc (AIM: GDR) has highlighted comments from UK Health Minister Preet Kaur Gill MP, who cited rapid pharmacogenetic testing for antibiotic-induced hearing loss as a practical example of personalised
RNS Hotlist with Zak Mir: LFT, DFDV, FUM, SOLI, SBTX, ECO, GDR, GUN, TAP, PORV & CREO
Lift Global Ventures plc (AQSE:LFT), an investment and acquisition company focused on foundational artificial intelligence, announced that it has completed a strategic investment in FourJaw Manufacturing Analytics Ltd, a UK scale-up
genedrive partners with Thermo Fisher on NHS testing
genedrive plc (AIM: GDR) has entered into a product development collaboration with Thermo Fisher Scientific to develop a high-throughput CYP2C19 pharmacogenetic test for deployment on Thermo Fisher’s QuantStudio™ 5 Dx
RNS Hotlist with Zak Mir: KEN, WSBN, EPP, AAU, MDH, KZG, GDR, BHL, FORG, GGP, EARN, PALM, POLB & BSFA
Kendrick Resources Plc (KEN), the mineral exploration and development company, announced a fundraising of £1,764,000 from Directors, a U.S. managed fund, a U.S. family office and existing shareholders.
RNS Hotlist with Zak Mir: GLR, KMK, ASTR, PRD, MYX, GDR & FCH
Galileo Resources (GLR) reported on laboratory assays from the recent reverse circulation (“RC”) drilling completed on its 100% owned prospecting licence PL253 in the Kalahari Copperbelt (“KCB”) of Botswana.